Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation

被引:2
|
作者
Pawar, Vijay [1 ]
Kumar, H. Yogish [2 ]
Giridhar, Rajani [1 ]
Yadav, Mange Ram [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara 390001, India
[2] Delhi Inst Pharmaceut Sci & Res DIPSAR, New Delhi, India
关键词
6-MNA; lipophilicity; NSAID; salts; skin permeation; solubility; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERMEABILITY; NSAIDS;
D O I
10.3109/10717544.2014.894595
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to prepare salts of 6-methoxy-2-naphthylacetic acid (6-MNA) to improve its physicochemical properties for percutaneous application. 6-MNA, an active metabolite of non-steroidal anti-inflammatory drug nabumetone has long half life and has the tendency to penetrate well into synovial fluid. The physicochemical properties of 6-MNA salts were investigated by solubility measurements, differential scanning calorimetry (DSC) and infrared (IR). The DSC thermograms and Fourier transform infrared (FT-IR) spectra indicated that 6-MNA formed salts with organic and alkali metal bases. Among the series, salts formed with amine bases (ethanolamine, diethanolamine, triethanolamine and diethylamine) had lower melting points while alkali metal salt (sodium) had higher melting point than 6-MNA. The salts had higher solubilities than 6-MNA as determined in phosphate buffer at pH 5.0 and 7.4. There is no significant difference in partition coefficient (log P) values between salts and 6-MNA at pH 5.0 but, at pH 7.4, the log P values for the salts increased by 4-10 times as compared to 6-MNA. In vitro permeation studies showed that all the salts increased the flux in comparision to 6-MNA, and the ethanolamine salt (1b) was found to be having 7.7 and 9.4 times higher permeability as compared to 6-MNA at pH 5.0 and 7.4, respectively.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [21] A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes
    Matsumoto, Kaori
    Hasegawa, Tetsuya
    Ohara, Kosuke
    Takei, Chihiro
    Kamei, Tomoyo
    Koyanagi, Junichi
    Takahashi, Tamiko
    Akimoto, Masayuki
    XENOBIOTICA, 2020, 50 (07) : 783 - 792
  • [22] Simplex optimization of the variables affecting the micelle-stabilized room temperature phosphorescence of 6-methoxy-2-naphthylacetic acid and its kinetic determination in human urine
    Pulgarin, JAM
    Molina, AA
    Pardo, MTA
    ANALYTICAL BIOCHEMISTRY, 2005, 339 (01) : 157 - 164
  • [23] Simultaneous analysis of naproxen, nabumetone and its major metabolite 6-methoxy-2-naphthylacetic acid in pharmaceuticals and human urine by high-performance liquid chromatography
    Mikami, E
    Goto, T
    Ohno, T
    Matsumoto, H
    Nishida, M
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (05) : 917 - 925
  • [24] High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study
    Patel, Bhavin N.
    Sharma, Naveen
    Sanyal, Mallika
    Prasad, Arpana
    Shrivastav, Pranav S.
    BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (11) : 1213 - 1224
  • [25] Distal effect on mass spectral fragmentations of glycolamide esters of 6-methoxy-2-naphthylacetic acid (6-MNA) and the crystal structure of N,N'-dimethyl-glycolamide ester of 6-MNA
    Sharma, PD
    Kumar, L
    Chandiran, W
    Chandiran, SK
    Singh, T
    Venugopalan, P
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2004, 43 (08): : 1758 - 1764
  • [26] Effect of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of nabumetone, on the glycosaminoglycan synthesis of canine articular cartilage in vitro - Comparison with other nonsteroidal anti-inflammatory drugs
    Gentry, C
    Blower, P
    Spangler, R
    CLINICAL DRUG INVESTIGATION, 1995, 10 (06) : 355 - 364
  • [27] Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid
    Zhao, Ligang
    Li, Yan
    Fang, Liang
    Ren, Changshun
    Xu, Yongnan
    He, Zhonggui
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (07) : 814 - 826
  • [28] CONCENTRATION OF 6-METHOXY-2-NAPHTHYLACETIC ACID IN PLASMA, SYNOVIAL-FLUID AND SURROUNDING TISSUES OF PATIENTS WITH RHEUMATOID-ARTHRITIS OR OSTEOARTHRITIS AFTER A 4-DAYS-TREATMENT WITH NABUMETONE (ARTHAXAN)
    MIEHLKE, RK
    SCHNEIDER, S
    SORGEL, F
    MUTH, P
    HENSCHKE, F
    FEDDER, M
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1991, 50 (02): : 103 - 108
  • [29] Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid in vitro
    Matsumoto, Kaori
    Hasegawa, Tetsuya
    Ohara, Kosuke
    Kamei, Tomoyo
    Koyanagi, Junichi
    Akimoto, Masayuki
    XENOBIOTICA, 2021, 51 (02) : 155 - 166
  • [30] Naltrexone salt selection for enhanced transdermal permeation through microneedle-treated skin
    Milewski, Mikolaj
    Pinninti, Raghotham R.
    Stinchcomb, Audra L.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (08) : 2777 - 2786